Sai Ravi Pingali Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

3/2021

Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sai Ravi Pingali Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 01/2018
4	Infections 01/2020 - 01/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 08/2015
3	Multiple Myeloma 01/2022 - 11/2020
3	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 07/2014
2	Leukemia 12/2023 - 03/2021
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 01/2020
2	Cytokine Release Syndrome 03/2021 - 10/2020
2	Cardiotoxicity 03/2021 - 01/2019
2	COVID-19 03/2021 - 10/2020
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 01/2018
1	Lymphoma (Lymphomas) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021
1	Death (Near-Death Experience) 03/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2021
1	Pneumonia (Pneumonitis) 03/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Critical Illness (Critically Ill) 10/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2020
1	Polycythemia Vera 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Disease Progression 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Histiocytic Sarcoma 01/2019
1	Eosinophilia 01/2019
1	Viremia 01/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Meningoencephalitis 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Second Primary Neoplasms (Neoplasms, Second) 07/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2015

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 12/2023 - 10/2020
2	Bortezomib (Velcade)FDA Link 01/2022 - 01/2021
2	Proteasome InhibitorsIBA 01/2022 - 01/2021
2	Brentuximab VedotinIBA 01/2022 - 01/2018
2	NivolumabIBA 01/2020 - 01/2018
2	pembrolizumabIBA 01/2020 - 01/2018
2	IpilimumabIBA 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
1	AntibodiesIBA 12/2023
1	CholesterolIBA 12/2023
1	Cell Surface ReceptorsIBA 12/2023
1	Cytidine DeaminaseIBA 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	IceIBA 01/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	romidepsin (FK228)FDA Link 01/2022
1	carfilzomibIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 03/2021
1	Oxygen (Dioxygen)IBA 03/2021
1	EnzymesIBA 03/2021
1	CytokinesIBA 10/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2020
1	tocilizumab (atlizumab)FDA Link 10/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	ruxolitinibIBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2019
1	Muramidase (Lysozyme)IBA 01/2019
1	pegaspargase (Oncaspar)FDA Link 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018
1	ibrutinibIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Calcineurin InhibitorsIBA 08/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2015

Therapy/Procedure

6	Therapeutics 01/2023 - 07/2014
4	Drug Therapy (Chemotherapy) 12/2023 - 01/2019
3	Radiotherapy 01/2023 - 01/2018
2	Artificial Respiration (Mechanical Ventilation) 03/2021 - 10/2020
2	Transplantation 07/2017 - 08/2015
1	Length of Stay 03/2021
1	Biological Therapy 11/2020
1	Craniotomy 01/2019
1	Cell Transplantation 01/2018
1	Stem Cell Transplantation 01/2018
1	Conformal Radiotherapy 01/2018
1	Autologous Transplantation 07/2017